Titelbild von PolyPeptide GroupPolyPeptide Group
PolyPeptide Group

PolyPeptide Group

Arzneimittelherstellung

Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based APIs.

Info

PolyPeptide Group AG with its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) which specializes in the development and manufacturing of synthetic peptides and oligonucleotides used as active pharmaceutical ingredients (API) or intermediates in therapeutic products. It also produces a range of generic peptides and peptides used in cosmetics. The Group mainly serves pharmaceutical and biotech companies. By supporting its customers, PolyPeptide contributes to the health of millions of patients across the world. PolyPeptide provides its offering from pre-clinical through to commercial stages. Its active custom projects pipeline reflects the opportunities from novel drug therapies in development to fight both widespread and rare diseases. Established in 1952, PolyPeptide today runs a global network of six GMP-certified facilities in Europe, the U.S. and India. PolyPeptide’s shares (SIX: PPGN) are listed on SIX Swiss Exchange. Find out more about our current vacancies at: https://polypeptide.teamtailor.com/

Website
http://www.polypeptide.com
Branche
Arzneimittelherstellung
Größe
1.001–5.000 Beschäftigte
Hauptsitz
Baar
Art
Kapitalgesellschaft (AG, GmbH, UG etc.)
Gegründet
1996
Spezialgebiete
GMP Peptides, Generic Peptides, Non-GMP Peptides, Peptides, Cosmetic Peptides, Personalized medicine, Commercial Manufacturing, Green Chemistry, Generic API's, Active Pharmaceutical Ingredients, Oligonucleotides, Regulatory Support, R&D, GMP compliance, Innovation & Technology und Individualized peptides

Orte

Beschäftigte von PolyPeptide Group

Updates

  • Excited to have one of our experts, Trishul Shah, represented on the GLP-1 peptide panel discussion at ChemOutsourcing 2025! If you’re interested in the latest trends and opportunities in peptide therapeutics, don’t miss this session✨ 📆Wednesday September  3 at 11:30 AM

    Profil von Mark Alexay anzeigen

    President & CEO at ChemOutsourcing

    GLP-1 drug candidates in clinical development yield high margins for the CDMOs competing in this area. Need a CDMO to scale up your compound? Meet them all at ChemOutsourcing 2025! 

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite für PolyPeptide Group anzeigen

    25.229 Follower:innen

    🚀Join PolyPeptide on our unique growth journey – and help shape our future ERP foundation. PolyPeptide is well positioned in its market, with a solid track record of over one thousand distinct therapeutic peptides. Our vision is to be the most innovative peptides CDMO and our priority remains to meet the strong and increasing customer demand by delivering our growth strategy, contributing to the health of millions of patients.   As part of this ongoing growth journey, we are continuing to build our ERP function, designed to help customers develop products with efficient and sustainable technologies.   Come and support our continued expansion and modernize how we work across sites, systems, and teams. 🌍   This is not just an implementation project but a rare opportunity to build and shape the future ERP organization and architecture from day one. Join PolyPeptide and play a key role in how we connect data, processes, and people across our global business.   💡 We’re hiring 10 new ERP roles to form the foundation – the first 7 are now live:   ✅ ERP Head Head of ERP (SAP S/4HANA) – https://lnkd.in/d__-J8hF ✅ ERP Solution Architect – https://lnkd.in/dSJWBtyN   ✅ ERP Solution Specialist – https://lnkd.in/dYq3xwHw ✅ ERP Solution Manager Finance  – https://lnkd.in/d-bHdWb9 ✅ ERP Solution Manager Commercial & Sales  – https://lnkd.in/d7TKbuWy ✅ ERP Test & Release Manager  – https://lnkd.in/dt-cY9YT ✅ Compliance & Validation Specialist – https://lnkd.in/dSq28TTh The Global IS/IT team is mainly based in Malmö, with additional members at our other sites in Strasbourg, France, Braine-l’Alleud, Belgium and Ambernath, India. If you're based in the Skåne region or within commuting distance of one of these locations, this could be a great opportunity to join a growing international team.  We're proud to partner with Capax Recruitment to help us find the right people who are excited about shaping modern, scalable ERP solutions in the life sciences industry.  Are you ready to make an impact?  Let’s build something extraordinary – from the ground up.  #ERP #SAP #digitaltransformation #lifesciences #careeropportunity #PolyPeptide #CapaxRecruitment

    • Kein Alt-Text für dieses Bild vorhanden
  • 🦠 𝗪𝗼𝗿𝗹𝗱 𝗭𝗼𝗼𝗻𝗼𝘀𝗲𝘀 𝗗𝗮𝘆 – 𝗝𝘂𝗹𝘆 𝟲 Honoring the anniversary of the first rabies vaccination by Louis Pasteur, this day is a global reminder that over 𝟳𝟬% 𝗼𝗳 𝗲𝗺𝗲𝗿𝗴𝗶𝗻𝗴 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝘂𝘀 𝗱𝗶𝘀𝗲𝗮𝘀𝗲𝘀 𝗮𝗿𝗲 𝘇𝗼𝗼𝗻𝗼𝘁𝗶𝗰 in origin. At 𝗣𝗼𝗹𝘆𝗣𝗲𝗽𝘁𝗶𝗱𝗲, we support companies developing 𝗽𝗲𝗽𝘁𝗶𝗱𝗲-𝗯𝗮𝘀𝗲𝗱 𝘃𝗮𝗰𝗰𝗶𝗻𝗲𝘀 from pre-clinical research to commercialization. This review in Vaccine highlighted promising peptide candidates targeting key zoonoses is a perfect Sunday read: https://lnkd.in/gMppsjhB? 🔬 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝗲𝗱 𝗣𝗲𝗽𝘁𝗶𝗱𝗲 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗶𝗻 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 Brucellosis: Epitope-based vaccines using OMP31 and BLS peptides induce strong T-cell responses in murine models Leptospirosis: Synthetic peptides from LigA and LipL32 proteins show immunogenicity and protection in hamster models Ebola virus: Multi-epitope peptides targeting the glycoprotein GP generate protective immunity in mice Rabies: Mimotope and glycoprotein epitope peptides stimulate specific IgG but still require improved neutralization Toxoplasmosis: Peptides from SAG1 and ROP18 proteins offer partial protection in animal studies 🚀 𝗛𝗼𝘄 𝗣𝗼𝗹𝘆𝗣𝗲𝗽𝘁𝗶𝗱𝗲 𝗛𝗲𝗹𝗽𝘀 𝗠𝗼𝘃𝗲 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗙𝗼𝗿𝘄𝗮𝗿𝗱 • Process development for complex peptide constructs • GMP manufacturing of multi-epitope vaccines • Analytical support for regulatory submission • Tech transfer and scale-up from clinic to market From early research to global supply, we help innovators advance the next generation of peptide-based vaccines. 🌍 On this 𝗪𝗼𝗿𝗹𝗱 𝗭𝗼𝗼𝗻𝗼𝘀𝗲𝘀 𝗗𝗮𝘆, we reaffirm our commitment to supporting science that protects health worldwide. #WorldZoonosesDay #PeptideVaccines #ZoonoticDiseases #OneHealth #VaccineDevelopment #Polypeptide

  • Unternehmensseite für PolyPeptide Group anzeigen

    25.229 Follower:innen

    We are excited to announce that Tim Brandl, CFA has taken over additional responsibilities leading Investor Relations at PolyPeptide, in addition to his role as Head of Financial Planning & Analysis (“FP&A”). Combining FP&A and Investor Relations will allow us to better serve our shareholders and the investment community. Tim joined us in 2024 following a successful career with Lonza, where he held different roles within Finance and Corporate Development. He also brings with him a wealth of experience from the investment industry. Please join us in wishing Tim much success in his new dual role!

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite für PolyPeptide Group anzeigen

    25.229 Follower:innen

    At PolyPeptide Sweden we had the great pleasure of recognizing 17 jubilees, colleagues who worked for us 10, 15, 20, 25 and 30 years.  A special shout-out to our three team members who have been with us for 30 years 🎉  We celebrated this extraordinary milestone at our midsummer lunch🎂where we gathered to show our appreciation for the years of dedication, teamwork, knowledge, and passion.   At PolyPeptide, we bring trust in everything we do which these colleagues are true ambassadors of. It's their commitment, ideas, and excellence that shape our company. These milestones are not just numbers, they reflect long-lasting relationships, shared goals, and a workplace culture we’re proud of.  ✨  #jubilees #GreatPlaceToWork #GrowWithUs #PolyPeptideSweden

    • Kein Alt-Text für dieses Bild vorhanden
  • Last chance to register! Our webinar on Peptide Aggregation in Manufacturing goes live tomorrow, June 18. 🧪 Why attend? ·        Learn how to identify, monitor and control peptide aggregation ·        Gain practical insights, technical approaches and regulatory-aligned strategies to ensure the quality, efficacy and manufacturability of peptide therapeutics ·        Engage with industry experts in a live Q&A Rekai Djouhar, Anais Pujol- Collinson, DINESH PARMAR 🔗 Register now: https://lnkd.in/d5XU7p7C #Webinar #PeptideAggregation #Peptides #Pharma #Biotech 

    • Kein Alt-Text für dieses Bild vorhanden
  • Celebrating World Environment Day! 🌱 On June 5th, World Environment Day, our site in Ambernath, India, organized a series of impactful activities to promote sustainability and environmental awareness among employees: 🌳 Tree Plantation Drive: Employees planted saplings, enhancing biodiversity and cleaner air. 🚮 Waste Collection Drive: Partnering with a local NGO, we collected and responsibly disposed of plastic, e-waste, and old clothes. 🛍️ Eco-Friendly Gifts: Employees received cloth bags made from recycled fabric waste, promoting upcycling. 🍽️ Plastic-Free Cafeteria: We replaced plastic plates with stainless steel ones for sustainable dining. Small steps make a big impact. Together, we’re building a greener future! 🌎 💚 #WorldEnvironmentDay #Sustainability #GreenerFuture #PolyPeptideAmbernath

    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
  • We’re excited to invite you to our upcoming webinar, Peptide Aggregation in Manufacturing: Mechanisms, Challenges and Case Studies, taking place on June 18. 🎯 Ideal for professionals involved in peptide process development, formulation, analytical sciences and regulatory affairs who want to deepen their understanding of aggregation-related risks and how to manage them across the development lifecycle. 💡Gain practical insights, technical approaches and regulatory-aligned strategies. This session promises to equip you with knowledge to navigate the complexities of peptide aggregation. 📩 Register for this webinar to learn how to identify, monitor and control peptide aggregation: https://lnkd.in/d5XU7p7C   #peptides #PeptideAggregation #webinar #casestudies #xtalks

  • Join us at the International Oligonucleotides and Peptides Conference, IOPC, in Prague from June 9–11, 2025! One of PolyPeptide’s solutions to the rising peptide demand includes intensifying Solid Phase Peptide Synthesis (SPPS) for efficient, sustainable, and large-scale production. Don’t miss Fabien ROUSSET’s presentation: "Intensified Solid Phase Peptide Synthesis: From Development to Large-Scale Peptide Manufacturing" 🗓 Date: June 10, 2025 ⏰ Time: 3:05–3:20 PM Visit us at booth 17, where you can meet Daniel Öberg-Arendt, to discuss your peptide projects. #IOPC2025 #Peptides #Innovation #SPPS

    • Kein Alt-Text für dieses Bild vorhanden

Ähnliche Seiten

Finanzierung